QA: Johnson Johnson in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2023_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 60,979,000,000
1 IntangibleAssetsNetIncludingGoodwill 81,638,000,000
2 PropertyPlantAndEquipmentNet 18,962,000,000
3 remainder_Assets 20,439,000,000
4 LiabilitiesCurrent 45,226,000,000
5 LiabilitiesNoncurrent 40,671,000,000
6 remainder_Liabilities 22,098,000,000
7 CostOfGoodsAndServicesSold 29,857,340,560
8 SellingGeneralAndAdministrativeExpense 24,613,990,017
9 ResearchAndDevelopmentExpense 14,856,568,248
10 remainder_Expenses 3,274,115,215
11 remainder_Revenues 93,855,456,513
12 remainder_NetIncome -669,888,439
13 remainder_ComprehensiveNetIncome 2,011,409,311
  yvar yval
0 Assets 182,018,000,000
1 Liabilities 107,995,000,000
2 Expenses 72,602,014,040
3 Revenues 93,855,456,513
4 StockholdersEquity 74,023,000,000
5 NetIncome 20,583,554,034
6 ComprehensiveNetIncome 21,589,258,690
7 BaseVar 229,575,884,152
8 EconomicCapitalRatiobeforeLimitedLiability 1.26
9 EconomicCapitalRatio 2.50

Edgar->Model Mapping

Feature Distribution

Change over Time